BIOMAT Database Logo BIOMAT Database Logo

Chloroquine and proguanil prophylaxis in travellers to Kenya. 1992

A Zumla

UI MeSH Term Description Entries
D007630 Kenya A republic in eastern Africa, south of ETHIOPIA, west of SOMALIA with TANZANIA to its south, and coastline on the Indian Ocean. Its capital is Nairobi. Republic of Kenya
D002727 Proguanil A biguanide compound which metabolizes in the body to form cycloguanil, an anti-malaria agent. Chlorguanid,Chloroguanide,Bigumal,Chloriguane,Chloroguanide Hydrochloride,Paludrin,Paludrine,Proguanil Hydrochloride,Hydrochloride, Chloroguanide,Hydrochloride, Proguanil
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D006266 Health Education Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis. Community Health Education,Education, Health,Education, Community Health,Health Education, Community
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014195 Travel MOVEMENT across different GEOGRAPHIC LOCATIONS. Land Travel,Sea Travel,Land Travels,Sea Travels,Travel, Land,Travel, Sea,Travels,Travels, Land,Travels, Sea
D016778 Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Plasmodium falciparum Malaria,Malaria, Plasmodium falciparum

Related Publications

A Zumla
Chloroquine and proguanil prophylaxis in travellers to Kenya.
January 1992, Lancet (London, England),
A Zumla
Chloroquine and proguanil prophylaxis in travellers to Kenya.
January 1992, Lancet (London, England),
A Zumla
Chloroquine and proguanil prophylaxis in travellers to Kenya.
January 1992, Lancet (London, England),
A Zumla
Failure of chloroquine and proguanil prophylaxis in travellers to Kenya.
November 1991, Lancet (London, England),
A Zumla
Malarial prophylaxis with chloroquine/proguanil.
January 1987, The Medical journal of Australia,
A Zumla
Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.
December 2000, Lancet (London, England),
A Zumla
[Compliance in malaria prophylaxis with chloroquine and proguanil].
March 1991, Deutsche medizinische Wochenschrift (1946),
A Zumla
Diagnosis of malaria during chloroquine/proguanil prophylaxis.
January 1990, Lancet (London, England),
A Zumla
Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil.
June 1995, The Journal of infectious diseases,
A Zumla
Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.
March 1988, British medical journal (Clinical research ed.),
Copied contents to your clipboard!